What is the difference between Saxagliptin and Sitagliptin?

Saxagliptin and Sitagliptin are both DPP-4 Inhibitors, so they work through the same broad mechanism. They differ in dosing, half-life, side-effect frequency, and how individual patients tolerate them. See the head-to-head sections below for the specifics.

Can Saxagliptin and Sitagliptin be used for the same conditions?

Both medications are prescribed for overlapping indications including Type 2 Diabetes Mellitus. Always verify with your prescriber and the current FDA label before switching.

Is Onglyza the same as Januvia?

No. Onglyza (Saxagliptin) and Januvia (Sitagliptin) are distinct medications. They are sometimes confused because of similar branding or because they treat overlapping conditions, but they have different active ingredients and different safety profiles.

Which has fewer side effects, Saxagliptin or Sitagliptin?

Side-effect frequency varies by individual. The side-effect comparison section on this page shows FAERS-reported events for each drug side by side. FAERS is voluntary reporting, so it reflects what patients and clinicians chose to report, not absolute population risk.

Can I switch from Saxagliptin to Sitagliptin?

Switching medications should always be done under prescriber supervision. The "patient stories" section on this page includes accounts from people who have made the switch and what their transition felt like, but those are individual experiences, not protocols.

Saxagliptin vs Sitagliptin

Compare Saxagliptin (Onglyza) and Sitagliptin (Januvia) — clinical data, side effects, and patient experiences.

Saxagliptin

Onglyza · DPP-4 Inhibitor

How it works

Inhibits DPP-4 enzyme to increase incretin levels, enhancing glucose-dependent insulin secretion and suppressing glucagon.

Approved for

Type 2 Diabetes Mellitus

FDA: 2009OralTablet

Sitagliptin

Januvia, ZITUVIMET · DPP-4 Inhibitor

How it works

Inhibits dipeptidyl peptidase-4 (DPP-4) enzyme, slowing the inactivation of incretin hormones GLP-1 and GIP, thereby increasing insulin release and decreasing glucagon levels in a ...

Approved for

Type 2 Diabetes Mellitus

t½: 12.4 hoursFDA: 2006OralTablet

Quick Comparison

SaxagliptinSitagliptin

Drug Class

DPP-4 Inhibitor

Route

Oral

Half-Life

—

12.4 hours

FDA Approved

2009

2006

Pregnancy

—

Efficacy Rating

0.0/10

7.0/10

Tolerability

0.0/10

9.0/10

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

Saxagliptin

Diarrhea

1-10%

Nausea

1-10%

Drug Not Working

1-10%

Dizziness

1-10%

Headache

1-10%

Fatigue

1-10%

Weight Loss

1-10%

Vomiting

1-10%

Sitagliptin

Headache

1-10%

Nausea

1-10%

Hypoglycemia

0.1-1%

FDA Warnings

Saxagliptin

Heart failure risk
Pancreatitis
Severe joint pain

Sitagliptin

Reports of acute pancreatitis
Severe joint pain reported post-marketing

Community Sentiment Analysis

Based on 15 Reddit discussions

Saxagliptin

positive

0 threads

Sitagliptin

40%

positive

15 threads

Community-Reported Side Effects

% of discussions mentioning each side effect

Head-to-Head Ratings

Patient Real-World Experience

Based on 1 verified patient review

Saxagliptin (0)

Sitagliptin (1)

Efficacy

0.0/107.0/10

Tolerability

0.0/109.0/10

Overall Satisfaction

0.0/108.0/10

Saxagliptin Side Effects

No data yet

Sitagliptin Side Effects

No data yet

Avg. Duration

0 months

0% still taking

Avg. Duration

18 months

100% still taking

Saxagliptin vs Sitagliptin: What You Should Know

Key Differences

Both Saxagliptin and Sitagliptin belong to the DPP-4 Inhibitor class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients.

Shared Indications

Both medications are approved for Type 2 Diabetes Mellitus. When two drugs treat the same condition, the choice between them often depends on the patient's medical history, other medications, tolerability, and prescriber preference.

Patient Experience

Sitagliptin has an average efficacy rating of 7.0/10 and tolerability of 9.0/10 across 1 patient review. Patient-reported outcomes provide real-world context beyond clinical trials, though individual responses to medication vary significantly..

Safety Considerations

Saxagliptin carries 3 FDA warnings. Sitagliptin carries 2 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

Metformin vs Sitagliptin→Sitagliptin vs SITAGLIPTIN AND METFORMIN HYDROCHLORIDE→LINAGLIPTIN AND METFORMIN HYDROCHLORIDE vs Sitagliptin→GLIMEPIRIDE vs Sitagliptin→Semaglutide vs Sitagliptin→Sitagliptin vs TIRZEPATIDE→

Primary sources

Every figure on this comparison links back to its primary source. See data sources and methodology for the full provenance trail.

Saxagliptin: DailyMed label · FAERS adverse events · ClinicalTrials.gov
Sitagliptin: DailyMed label · FAERS adverse events · ClinicalTrials.gov

Loading comparison data...

Saxagliptin vs Sitagliptin

Compare Saxagliptin (Onglyza) and Sitagliptin (Januvia) — clinical data, side effects, and patient experiences.

Saxagliptin

Onglyza · DPP-4 Inhibitor

How it works

Inhibits DPP-4 enzyme to increase incretin levels, enhancing glucose-dependent insulin secretion and suppressing glucagon.

Approved for

Type 2 Diabetes Mellitus

FDA: 2009OralTablet

Sitagliptin

Januvia, ZITUVIMET · DPP-4 Inhibitor

How it works

Inhibits dipeptidyl peptidase-4 (DPP-4) enzyme, slowing the inactivation of incretin hormones GLP-1 and GIP, thereby increasing insulin release and decreasing glucagon levels in a ...

Approved for

Type 2 Diabetes Mellitus

t½: 12.4 hoursFDA: 2006OralTablet

Quick Comparison

SaxagliptinSitagliptin

Drug Class

DPP-4 Inhibitor

Route

Oral

Half-Life

—

12.4 hours

FDA Approved

2009

2006

Pregnancy

—

Efficacy Rating

0.0/10

7.0/10

Tolerability

0.0/10

9.0/10

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

Saxagliptin

Diarrhea

1-10%

Nausea

1-10%

Drug Not Working

1-10%

Dizziness

1-10%

Headache

1-10%

Fatigue

1-10%

Weight Loss

1-10%

Vomiting

1-10%

Sitagliptin

Headache

1-10%

Nausea

1-10%

Hypoglycemia

0.1-1%

FDA Warnings

Saxagliptin

Heart failure risk
Pancreatitis
Severe joint pain

Sitagliptin

Reports of acute pancreatitis
Severe joint pain reported post-marketing

Community Sentiment Analysis

Based on 15 Reddit discussions

Saxagliptin

positive

0 threads

Sitagliptin

40%

positive

15 threads

Community-Reported Side Effects

% of discussions mentioning each side effect

Head-to-Head Ratings

Patient Real-World Experience

Based on 1 verified patient review

Saxagliptin (0)

Sitagliptin (1)

Efficacy

0.0/107.0/10

Tolerability

0.0/109.0/10

Overall Satisfaction

0.0/108.0/10

Saxagliptin Side Effects

No data yet

Sitagliptin Side Effects

No data yet

Avg. Duration

0 months

0% still taking

Avg. Duration

18 months

100% still taking

Saxagliptin vs Sitagliptin: What You Should Know

Key Differences

Shared Indications

Patient Experience

Safety Considerations

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.